The prognosis of patients with gastrointestinal stromal tumors is significantly impacted by gastrointestinal bleeding.
Major bleeding was low overall, but the findings align with other large datasets showing greater risk with rivaroxaban.
Experts discuss PPI use for GI protection in patients on antithrombotics, highlighting risk factors, dosing, drug ...
Introduction Endoscopic hand-suturing (EHS) has emerged as a promising modality in gastrointestinal (GI) endoscopic procedures. Reports on its effectiveness in clinical practice remain limited due to ...
GBS scores were calculated and outcome data (hospital interventions for GI bleeding and death ... in the low-risk group was significantly lower than that of other individuals with complete ...
16h
Hosted on MSNGLP-1 Drugs and Colonoscopy; GI Symptoms Post-COVID; Identifying High-Risk Barrett'sA systematic review and meta-analysis of five studies suggested that patients on GLP-1 receptor agonists were more likely to ...
Longevity is increasing worldwide, and Dr Ray O’Connor takes a look at some of the most recent clinical studies on the subject of gerontology ...
Dr Ravinder K Gupta, Dr Akhilpreet Kaur Anemia is a serious global public health problem that particularly affects young ...
6h
The Healthy on MSNOTC Medication Mistakes: Doctors Advise You To Avoid Doing TheseJust because you can buy a medication over the counter doesn’t mean it’s always safe. Here’s how you should really be using ...
Compared with rivaroxaban, abelacimab is associated with fewer bleeding events in patients with AF and moderate to high risk for stroke.
Colon cancer is rapidly increasing among the youth, possibly due to unhealthy lifestyles. Gut microbiome imbalances are ...
It’s 8.30am on a Wednesday and I’m with 60 people, crowded into a room in the Auckland City Mission’s HomeGround building, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results